ArticleFrontiers in immunology2023

Efficacy and safety of definitive chemoradiotherapy with or without induction immune checkpoint inhibitors in patients with stage III non-small cell lung cancer.

Yin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.